{
    "ticker": "PGYWW",
    "name": "Progenity, Inc.",
    "description": "Progenity, Inc. is a biotechnology company focused on transforming the landscape of genetic testing and personalized medicine. Founded in 2010 and headquartered in San Diego, California, Progenity specializes in developing innovative testing solutions that empower individuals with critical information about their health. The company\u2019s flagship offerings include non-invasive prenatal testing (NIPT) and advanced genetic tests aimed at improving patient outcomes. Progenity is committed to providing comprehensive genetic insights to patients and healthcare providers, facilitating informed decision-making regarding health management and treatment options. With a team of experienced scientists and healthcare professionals, Progenity integrates cutting-edge technology with a patient-centric approach, ensuring that genetic testing is accessible, accurate, and reliable. The company continually invests in research and development to expand its product portfolio and enhance existing tests, positioning itself as a leader in the genetic testing market. As part of its mission, Progenity strives to deliver high-quality, clinically relevant tests that not only meet the needs of patients but also contribute to the broader understanding of genetic health.",
    "industry": [
        "Biotechnology",
        "Genetic Testing"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2010",
    "website": "https://progenity.com",
    "ceo": "Harry Stylli",
    "social_media": {
        "twitter": "https://twitter.com/progenity",
        "linkedin": "https://www.linkedin.com/company/progenity-inc"
    },
    "investor_relations": "https://investors.progenity.com",
    "key_executives": [
        {
            "name": "Harry Stylli",
            "position": "CEO"
        },
        {
            "name": "Eric T. M. Davis",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genetic Testing",
            "products": [
                "Non-Invasive Prenatal Testing (NIPT)",
                "Advanced Genetic Tests"
            ]
        }
    ],
    "seo": {
        "meta_title": "Progenity, Inc. | Genetic Testing and Personalized Medicine",
        "meta_description": "Explore Progenity, Inc., a leader in biotechnology focused on genetic testing and personalized medicine. Learn about our innovative testing solutions and commitment to patient health.",
        "keywords": [
            "Progenity",
            "Genetic Testing",
            "Biotechnology",
            "Personalized Medicine",
            "Prenatal Testing"
        ]
    },
    "faq": [
        {
            "question": "What is Progenity known for?",
            "answer": "Progenity is known for its innovative genetic testing solutions, including non-invasive prenatal testing and advanced genetic tests."
        },
        {
            "question": "Who is the CEO of Progenity?",
            "answer": "Harry Stylli is the CEO of Progenity, Inc."
        },
        {
            "question": "Where is Progenity headquartered?",
            "answer": "Progenity is headquartered in San Diego, California, USA."
        },
        {
            "question": "What types of products does Progenity offer?",
            "answer": "Progenity offers genetic testing products, including Non-Invasive Prenatal Testing (NIPT) and advanced genetic tests."
        },
        {
            "question": "When was Progenity founded?",
            "answer": "Progenity was founded in 2010."
        }
    ],
    "competitors": [
        "NTRA",
        "GENE",
        "ILMN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "VRTX"
    ]
}